期刊文献+

急性肺栓塞合并2型糖尿病的临床特征分析 被引量:1

Clinical analysis of acute pulmonary embolism with type 2 diabetes mellitus
原文传递
导出
摘要 目的:探讨急性肺栓塞合并2型糖尿病患者的临床特征及复发率。方法回顾性分析2010年1月至2015年12月在首都医科大学良乡教学医院住院诊断为急性肺栓塞患者126例,其中合并2型糖尿病患者43例为观察组,其余83例为对照组,分析两组间临床表现、合并症、实验室检查结果、栓子部位、危险分层及肺栓塞复发率的不同。结果两组间年龄、性别及临床表现未见明显差异,观察组合并呼吸衰竭、冠心病及肺部感染较对照组明显增加(P〈0.05);观察组肌酸激酶(CK)、乳酸脱氢酶(LDH)、空腹血糖(Glu)、全血肌钙蛋白I(cTnI)、N末端脑钠肽前体(NT-pro-BNP)、肌酐(CREA)均较对照组明显升高(P〈0.05);观察组危险分层中高危患者较对照组多(P〈0.05);观察组肺栓塞复发率较对照组高(P〈0.05)。结论急性肺栓塞合并2型糖尿病病情多较重,合并症多,易出现呼吸衰竭,复发率高,临床上应重视此类患者,严格控制危险因素,预防复发。 Objective To explore the clinical features and recurrence rates of acute pulmonary embolism (APE) with type 2 diabetes mellitus(DM2). Methods 126 patients with acute pulmonary embolism were retrospectively analysed from January 2010 to December 2015. All patients were divided into two groups:observation group (APE with DM2,43 cases) and control group(APE without DM2,83 cases).The differences of clinical manifestations, complications,laboratory results,thrombus localizations,risk stratification and the recurrence rates of acute pulmonary embolism were analysed between the two groups. Results There were no significant differences in age,sex and clinical manifestations between the two groups. The combination of respiratory failure,coronary heart disease and pneumonia were more frequently seen in observation group(P〈0.05). The level of creatine kinase, lactate dehydrogenase, fasting blood glucose,cTnI,NT-pro-BNP, CREA were obviously higher than control group(P〈0.05). A higher risk stratification and recurrence rate were observed in the bservation group(P〈0.05). Conclusion Patients with acute pulmonary embolism and type 2 diabetes mellitus are more serious and more affected by complications and a higher recurrence rate,thus,we should give more attention to these patients and reduce the recurrence rate.
出处 《中国临床实用医学》 2016年第3期28-30,共3页 China Clinical Practical Medicine
关键词 肺栓塞 2型糖尿病 复发率 Pulmonary embolism Type 2 diabetes mellitus Recurrence rate
  • 相关文献

参考文献10

  • 1Petrauskiene V,Falk M,Waernbaum I,et al.The risk of venous thromboembolism is markedly elevated in patients with diabetes[J].Diab etologia,2005,48(5):1017-1021.
  • 2Lowe GD.Common risk factors for both arterial and venous thrombosis[J].Br J Haematol,2008,140(5):488-495.
  • 3Task Force on Pulmonary Embolism,European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism[J].Eur Heart J,2000,21 ( 16): 1301 - 1336.
  • 4Ageno W,Becattini C,Brighton T,et al.Cardiovascular risk factors and venous thromboembolism: a meta-analysis[J]. Circulation,2008,117(1):93-102.
  • 5Goldhaber SZ,Grodstein F,Stampfer MJ,et al.A prospective study of risk factors for pulmonary embolism in women[J].JAMA,1997,277(8):642- 645.
  • 6Grady D,Wenger NK,Herrington D,ct al.Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study[J].Ann Intern Med,2000,132(9):689-696.
  • 7张伟,王丁一,崔娣,刘东戈.2型糖尿病合并肺栓塞12例尸检分析[J].中国临床医生杂志,2015,43(6):42-44. 被引量:13
  • 8Saboor M,Moinuddin,Ajmal M,et al. Functional status of vascular endothelium in diabetes mellitus[J].J Ayub Med Coil Abbottabad,2014,26(2):239-243.
  • 9李娟,李书琴,吴红敏,刘春峰,魏克伦.肺出血幼兔右心室压力及肺毛细血管内皮细胞超微结构的改变[J].中华儿科杂志,2000,38(3):147-149. 被引量:21
  • 10季巧英,舒彩敏,方双燕,冯兰芳,杨琼芳.急性肺栓塞患者1年内复发静脉血栓危险因素研究[J].医学研究杂志,2013,42(10):159-161. 被引量:3

二级参考文献32

  • 1周玉杰,杨士伟.肺动脉瓣感染性心内膜炎致肺栓塞1例[J].中国医学前沿杂志(电子版),2013,5(5):64-67. 被引量:4
  • 2Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis[J]. Lancet,2012,379(9828) :1835 - 1846.
  • 3Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for ve- nous thromboembolic disease: American College of Chest Physicians Evidence - Based Clinical Practice Guidelines ( 8th Edition) [ J ]. Chest,2008,133(Suppl 6) :454S -545S.
  • 4British Thoracic Society Standards of Care Committee Pulmonary Em- bolism Guideline Development Group. British Thoracic Society guide- lines for the management of suspected acute pulmonary embolism[ J]. Thorax ,2003,58 ( 6 ) :470 - 483.
  • 5Kearon C ,Gent M, Hirsb JA,et al. comparison of three months of an- ticoagulation with extended anticoagulation for a first episode of idio- pathic venous thromboembolism [ J]. N Engl J Med, 1999,340 ( 12 ) : 901 - 907.
  • 6Tormoen GW, Haley KM, Levine RL, et al. Do circulating tumor ceils play a role in coagulation and thrombosis? [ J]. Front Oncol,2012, 10(2)115.
  • 7Torbicki A, Konstantinides S, Perrier A,et al. Guidelines on the diag- nosis and management of acute pulmonary embolism : the task force for the diagnosis and management of acute pulmonary embolism of Euro- pean Society of Cardiology [ J ]. Eur Heart J, 2008, 29 ( 18 ) : 2276 -2315.
  • 8Koracevic GP. Importance of meta - analysis of long - term trials of low - molecular - weight heparin vs vitamin K antagonist in pulmonary embolism[J]. Am J Emerg Med,2013,31(3) :627 -628.
  • 9Lippi G, Favaloro E J, Franchini M. Paradoxical thrombosis part 1 : fac- tor replacement therapy,inherited clotting factor defieiencies and pro- longed APTT[ J]. J Thromb Thrombolysis,2012,34(3 ) :360 - 366.
  • 10Anand S,Bates S, Ginsberg J,et al. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times [ J ]. Arch Intern Med, 1999,159 ( 17 ) : 2029 - 2032.

共引文献34

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部